Nipple-sparing mastectomy: what is the best evidence for safety?
Jensen
J Arthur
JA
John Wayne Cancer Center, Geffen School of Medicine at the University of California, Los Angeles, 2001 Santa Monica Boulevard, Suite 790W, Santa Monica, Calif. 90404, dr.j.jensen@gmail.com.
D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D018572:Disease-Free Survival; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015414:Mastectomy, Subcutaneous / Q000009:adverse effects / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology*; D009367:Neoplasm Staging; D009558:Nipples; D018579:Patient Selection; D011379:Prognosis; D017751:Safety Management; D016019:Survival Analysis